SGLT2 Inhibitors: Heart and Kidney Protection Beyond Blood Sugar 2nd mayo 202621st marzo 2026 por Living Diabetes Editorial Team SGLT2 Inhibitors: Heart and Kidney Protection Beyond Blood Sugar: how this medication class protects kidney function in diabetes — eligibility, evidence.